ArticleCancer biomarkers : section A of Disease markers2017

Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment.

Alessandra Trojani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.